NCT07102836View on ClinicalTrials.gov

COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

PHASE2RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

August 7, 2025

Primary Completion Date

February 7, 2026

Study Completion Date

May 7, 2026

Conditions

Indirect HyperbilirubinemiaNeonatal

Interventions

DRUG

Zinc sulfate

Oral zinc sulfate syrup in a dose providing 5mg elemental zinc daily as adjuvant to phototherapy.

DRUG

Probiotic lactobacillus rhamnosus GG

Oral Probiotic Lactobacillus rhamnosus GG drops daily as adjuvant to phototherapy.

Trial Locations (1)

63100

RECRUITING

Sadiq Abbasi Hospital, QAMC, Bahawalpur, Bahawalpur

All Listed Sponsors

lead

Quaid-e-Azam Medical College

OTHER

NCT07102836 - COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY | Biotech Hunter | Biotech Hunter